Abbott FreeStyle Libre 3 Glucose Sensor Investigation
Lieff Cabraser is investigating reports of serious injuries related to inaccurate glucose readings by Abbott Diabetes Care’s FreeStyle Libre 3 and Libre 3 Plus glucose sensors. According to Abbott and the FDA, the devices have been linked to 736 severe adverse events and 7 reported deaths worldwide.
2025 FDA Safety Alert
On December 2, 2025, the FDA issued an Early Alert after Abbott initiated a “medical device correction” for affected sensors. The FDA reports that some sensors may display incorrect low readings, which could cause users to skip insulin doses or consume unnecessary carbohydrates, putting them at risk for serious medical complications.
Abbott reports that about three million sensors are affected, and the FDA and Abbott advise users to stop using impacted devices. To determine if your device is part of the recall, please visit the FDA’s web page.
Talk to us today
If you used an Abbott FreeStyle Libre 3 or Libre 3 Plus sensor and experienced a serious injury, we urge you to contact an experienced defective medical device lawyer at Lieff Cabraser today about your legal rights. There is no charge or obligation for our review of your case, and the information you provide will help us hold Abbott accountable.
Related News
- US Food & Drug Administration Early Alert
Updated December 2, 2025 - 7 Deaths, hundreds of injuries may be linked to diabetes glucose monitor errors, FDA says
December 3, 2025
CBS News - Seven deaths possibly linked to malfunctioning glucose monitors
December 3, 2025
USA Today









